Summary

Percutaneous Coronary Intervention Market Research Report Forecast till 2030

Overview
The Percutaneous Coronary Intervention Market is anticipated to register a notable CAGR of 8.86% during the forecast period.
The percutaneous coronary intervention market is set for vigorous growth driven by mechanical progressions, expanding commonness of cardiovascular infections, and a rising maturing populace. With an emphasis on insignificantly obtrusive techniques and creative stent innovations, the market is ready to observe supported extension, offering worked on quiet results, and adding to the development of interventional cardiology.
The normal growth in the market can be ascribed to the rising predominance of heart sicknesses and expanding inclination for negligibly obtrusive methodology.
Throughout recent years, the quantity of death and handicaps brought about via cardiovascular infection has ceaselessly expanded all over the planet. The issue, which incorporates coronary illness and stroke, was answerable for 33% of the passings across the globe in 2019. For example, in 2019, the World Wellbeing Organization assessed that almost 17.9 million people passed on from cardiovascular illnesses, representing 32% of every worldwide casualty. Respiratory failures and strokes were liable for 85% of these fatalities. Unfortunate food, actual latency, cigarette use, and hazardous liquor utilization are the most major conduct risk factors for coronary illness and stroke.
Market Segmentation
The Percutaneous Coronary Intervention Market segmentation, based on product type, includes coronary stents, ballon catheters, coronary guidewires, guiding catheters, guiding sheaths, diagnostic catheters, crossing catheters, inflation device, guidance system, peripheral thrombectomy system, embolic protection system, and accessories.
The Percutaneous Coronary Intervention Market segmentation, based on vascular access, includes radial and femoral.
The Percutaneous Coronary Intervention Market segmentation, based on end user, includes hospitals & clinics, ambulatory surgical centers, and others.
Regional Insights
The North America percutaneous coronary intervention market accounted for the largest market share in 2022. North America is further divided into the US and Canada. North America held the largest market share due to the increase in demand for minimally invasive procedures, increasing prevalence of cardiovascular diseases, and unhealthy lifestyle habits propelling regional market growth over the forecast period.
Europe percutaneous coronary intervention market accounted for the second-largest market share due to unhealthy lifestyle habits, increasing geriatric population, and extensive R&D activities. Furthermore, the Germany percutaneous coronary intervention market is attributed to hold the largest market share.
The Asia-Pacific percutaneous coronary intervention market is expected to be the fastest growing from 2023 to 2032 due to rising income levels, an increase in the prevalence of cardiovascular diseases, and better healthcare infrastructure. Moreover, China percutaneous coronary intervention market accounted to hold the largest market share, and the India percutaneous coronary intervention market is projected to be the fastest growing market in the Asia-Pacific region.
Major Players
Key Companies in the Percutaneous Coronary Intervention market includes Boston Scientific Corporation (US), Abbott (US), MicroPort Scientific Corporation (China), Terumo Corporation (Japan), Medtronic (Ireland), Cook (US), APT Medical Inc (China), Merit Medical System (US), Becton, Dickinson, and Company (US), Braun SE (Germany), Cardinal Health (US), Meril Life Sciences Pvt. Ltd (India), PLS Minimally Invasive International Medical Co Ltd (China), and Lepu Medical Technology Co., Ltd (China).

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

1.1 OVERVIEW

2 MARKET INTRODUCTION

2.1 DEFINITION

2.2 SCOPE OF THE STUDY

2.3 RESEARCH OBJECTIVE

2.4 LIST OF ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

3.1 DATA MINING

3.2 SECONDARY RESEARCH

3.3 PRIMARY RESEARCH

3.3.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS

3.3.2 BREAKDOWN OF PRIMARY RESPONDENTS

3.4 FORECASTING TECHNIQUES

3.5 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION

3.5.1 BOTTOM-UP APPROACH

3.5.2 TOP-DOWN APPROACH

3.6 DATA TRIANGULATION

3.7 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW

4.2 DRIVERS

4.2.1 RISING PREVALENCE OF HEART DISEASES

4.2.2 INCREASING PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES

4.3 RESTRAINTS

4.3.1 RISK OF INFECTION

4.3.2 COMPLICATIONS DURING CARDIAC CATHETERIZATION

4.4 OPPORTUNITIES

4.4.1 GROWING TECHNOLOGICAL ADVANCEMENTS

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS

5.1.1 R&D

5.1.2 MANUFACTURING

5.1.3 DISTRIBUTION AND SALES

5.1.4 POST-SALES MONITORING

5.2 PORTER’S FIVE FORCES MODEL

5.2.1 THREAT OF NEW ENTRANTS

5.2.2 BARGAINING POWER OF SUPPLIERS

5.2.3 THREAT OF SUBSTITUTES

5.2.4 BARGAINING POWER OF BUYERS

5.2.5 INTENSITY OF RIVALRY

5.3 IMPACT OF COVID-19 ON THE GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET

5.3.1 IMPACT ON SUPPLY CHAIN

5.3.2 IMPACT ON KEY PLAYERS

5.3.3 IMPACT ON DEMAND AND SUPPLY

5.4 INSIGHTS: TECHNOLOGICAL ADVANCEMENT FOR PERCUTANEOUS CORONARY INTERVENTION PRODUCTS

6 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE

6.1 OVERVIEW

6.1.1 CORONARY STENTS

6.1.2 BALLON CATHETERS

6.1.3 CORONARY GUIDEWIRES

6.1.4 GUIDING CATHETERS

6.1.5 GUIDING SHEATHS

6.1.6 DIAGNOSTIC CATHETERS

6.1.7 CROSSING CATHETERS

6.1.8 INFLATION DEVICE

6.1.9 GUIDANCE SYSTEM

6.1.10 PERIPHERAL THROMBECTOMY SYSTEM

6.1.11 EMBOLIC PROTECTION SYSTEM

6.1.12 ACCESSORIES

7 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS

7.1 OVERVIEW

7.1.1 RADIAL

7.1.2 FEMORAL

8 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER

8.1 OVERVIEW

8.1.1 HOSPITALS & CLINICS

8.1.2 AMBULATORY SURGICAL CENTERS

8.1.3 OTHERS

9 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, BY REGION

9.1 OVERVIEW

9.2 NORTH AMERICA

9.2.1 US

9.2.2 CANADA

9.3 EUROPE

9.3.1 GERMANY

9.3.2 FRANCE

9.3.3 UK

9.3.4 ITALY

9.3.5 SPAIN

9.3.6 SWITZERLAND

9.3.7 NETHERLAND

9.3.8 BELGIUM

9.3.9 POLAND

9.3.10 REST OF EUROPE

9.4 ASIA-PACIFIC

9.4.1 CHINA

9.4.2 JAPAN

9.4.3 INDIA

9.4.4 AUSTRALIA

9.4.5 SOUTH KOREA

9.4.6 SINGAPORE

9.4.7 THAILAND

9.4.8 VIETNAM

9.4.9 REST OF ASIA-PACIFIC

9.5 REST OF THE WORLD

9.5.1 AFRICA

9.5.2 LATIN AMERICA

9.5.3 MIDDLE EAST

10 COMPETITIVE LANDSCAPE

10.1 OVERVIEW

10.2 COMPETITIVE BENCHMARKING

10.3 MARKET SHARE ANALYSIS MAJOR PLAYER

10.3.1 BOSTON SCIENTIFIC CORPORATION

10.3.2 ABBOTT

10.3.3 MEDTRONIC

10.3.4 TERUMO CORPORATION

10.3.5 MICROPORT SCIENTIFIC CORPORATION

10.4 MAJOR GROWTH STRATEGY IN THE GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET

10.5 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET

10.6 KEY DEVELOPMENT ANALYSIS

10.7 KEY DEVELOPMENTS & GROWTH STRATEGIES

10.7.1 PRODUCT LAUNCH / PRODUCT APPROVAL

10.7.2 AGREEMENT

10.8 MAJOR PLAYERS FINANCIAL

10.8.1 SALES (USD MILLION), 2022

10.8.2 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2022

11 COMPANY PROFILES

11.1 BOSTON SCIENTIFIC CORPORATION

11.1.1 COMPANY OVERVIEW

11.1.2 FINANCIAL OVERVIEW

11.1.3 PRODUCTS OFFERED

11.1.4 KEY DEVELOPMENTS

11.1.5 SWOT ANALYSIS

11.1.6 KEY STRATEGIES

11.2 ABBOTT

11.2.1 COMPANY OVERVIEW

11.2.2 FINANCIAL OVERVIEW

11.2.3 PRODUCTS OFFERED

11.2.4 KEY DEVELOPMENTS

11.2.5 SWOT ANALYSIS

11.2.6 KEY STRATEGIES

11.3 MEDTRONIC

11.3.1 COMPANY OVERVIEWS

11.3.2 FINANCIAL OVERVIEW

11.3.3 PRODUCTS OFFERED

11.3.4 KEY DEVELOPMENTS

11.3.5 SWOT ANALYSIS

11.3.6 KEY STRATEGIES

11.4 COOK

11.4.1 COMPANY OVERVIEW

11.4.2 FINANCIAL OVERVIEW

11.4.3 PRODUCTS OFFERED

11.4.4 KEY DEVELOPMENTS

11.4.5 KEY STRATEGIES

11.5 MERIT MEDICAL SYSTEM

11.5.1 COMPANY OVERVIEW

11.5.2 FINANCIAL OVERVIEW

11.5.3 PRODUCTS OFFERED

11.5.4 KEY DEVELOPMENTS

11.5.5 KEY STRATEGIES

11.6 TERUMO CORPORATION

11.6.1 COMPANY OVERVIEW

11.6.2 FINANCIAL OVERVIEW

11.6.3 PRODUCTS OFFERED

11.6.4 KEY DEVELOPMENTS

11.6.5 KEY DEVELOPMENTS

11.6.6 KEY STRATEGIES

11.7 APT MEDICAL INC

11.7.1 COMPANY OVERVIEW

11.7.2 FINANCIAL OVERVIEW

11.7.3 PRODUCTS OFFERED

11.7.4 KEY DEVELOPMENTS

11.7.5 KEY STRATEGIES

11.8 BECTON, DICKINSON, AND COMPANY

11.8.1 COMPANY OVERVIEW

11.8.2 FINANCIAL OVERVIEW

11.8.3 PRODUCTS OFFERED

11.8.4 KEY DEVELOPMENTS

11.8.5 SWOT ANALYSIS

11.8.6 KEY STRATEGIES

11.9 B. BRAUN SE

11.9.1 COMPANY OVERVIEW

11.9.2 FINANCIAL OVERVIEW

11.9.3 PRODUCTS OFFERED

11.9.4 KEY DEVELOPMENTS

11.9.5 SWOT ANALYSIS

11.9.6 KEY STRATEGIES

11.10 CARDINAL HEALTH

11.10.1 COMPANY OVERVIEW

11.10.2 FINANCIAL OVERVIEW

11.10.3 PRODUCTS OFFERED

11.10.4 KEY DEVELOPMENTS

11.10.5 KEY STRATEGIES

11.11 MERIL LIFE SCIENCES PVT. LTD

11.11.1 COMPANY OVERVIEWS

11.11.2 FINANCIAL OVERVIEW

11.11.3 PRODUCTS OFFERED

11.11.4 KEY DEVELOPMENTS

11.11.5 KEY STRATEGIES

11.12 PLS MINIMALLY INVASIVE INTERVENTIONAL MEDICAL CO., LTD

11.12.1 COMPANY OVERVIEW

11.12.2 FINANCIAL OVERVIEW

11.12.3 PRODUCTS OFFERED

11.12.4 KEY DEVELOPMENTS

11.12.5 KEY STRATEGIES

11.13 MICROPORT SCIENTIFIC CORPORATION

11.13.1 COMPANY OVERVIEW

11.13.2 FINANCIAL OVERVIEW

11.13.3 PRODUCTS OFFERED

11.13.4 KEY DEVELOPMENTS

11.13.5 KEY STRATEGIES

11.14 LEPU MEDICAL TECHNOLOGY CO., LTD

11.14.1 COMPANY OVERVIEW

11.14.2 FINANCIAL OVERVIEW

11.14.3 PRODUCTS OFFERED

11.14.4 KEY DEVELOPMENTS

11.14.5 KEY STRATEGIES

12 APPENDIX

12.1 REFERENCES

12.2 RELATED REPORTS

ページTOPに戻る

List of Tables/Graphs

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS

TABLE 2 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019–2032 (USD MILLION)

TABLE 3 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR CORONARY STENTS, BY REGION, 2019–2032 (USD MILLION)

TABLE 4 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY REGION, 2019–2032 (USD MILLION)

TABLE 5 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 6 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR CORONARY GUIDEWIRES, BY REGION, 2019–2032 (USD MILLION)

TABLE 7 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR GUIDING CATHETERS, BY REGION, 2019–2032 (USD MILLION)

TABLE 8 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR GUIDING SHEATHS, BY REGION, 2019–2032 (USD MILLION)

TABLE 9 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR DIAGNOSTICS CATHETERS, BY REGION, 2019–2032 (USD MILLION)

TABLE 10 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR CROSSING CATHETERS, BY REGION, 2019–2032 (USD MILLION)

TABLE 11 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR INFLATION DEVICE, BY REGION, 2019–2032 (USD MILLION)

TABLE 12 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR GUIDANCE SYSTEM, BY REGION, 2019–2032 (USD MILLION)

TABLE 13 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR PERIPHERAL THROMBECTOMY SYSTEM, BY REGION, 2019–2032 (USD MILLION)

TABLE 14 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR EMBOLIC PROTECTION SYSTEM, BY REGION, 2019–2032 (USD MILLION)

TABLE 15 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR ACCESSORIES, BY REGION, 2019–2032 (USD MILLION)

TABLE 16 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS, 2019–2032 (USD MILLION)

TABLE 17 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR RADIAL, BY REGION, 2019–2032 (USD MILLION)

TABLE 18 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR FEMORAL, BY REGION, 2019–2032 (USD MILLION)

TABLE 19 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 20 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR HOSPITALS & CLINICS, BY REGION, 2019–2032 (USD MILLION)

TABLE 21 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2019–2032 (USD MILLION)

TABLE 22 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD MILLION)

TABLE 23 GLOBAL: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY REGION, 2019–2032 (USD MILLION)

TABLE 24 NORTH AMERICA: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY COUNTRY, 2019–2032 (USD MILLION)

TABLE 25 NORTH AMERICA: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019–2032 (USD MILLION)

TABLE 26 NORTH AMERICA: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 27 NORTH AMERICA: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS, 2019–2032 (USD MILLION)

TABLE 28 NORTH AMERICA: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 29 US: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019–2032 (USD MILLION)

TABLE 30 US: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 31 US: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS, 2019–2032 (USD MILLION)

TABLE 32 US: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 33 CANADA: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019–2032 (USD MILLION)

TABLE 34 CANADA: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 35 CANADA: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS, 2019–2032 (USD MILLION)

TABLE 36 CANADA: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 37 EUROPE: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY COUNTRY, 2019–2032 (USD MILLION)

TABLE 38 EUROPE: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019–2032 (USD MILLION)

TABLE 39 EUROPE: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 40 EUROPE: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS, 2019–2032 (USD MILLION)

TABLE 41 EUROPE: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 42 GERMANY: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019–2032 (USD MILLION)

TABLE 43 GERMANY: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 44 GERMANY: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS, 2019–2032 (USD MILLION)

TABLE 45 GERMANY: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 46 FRANCE: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019–2032 (USD MILLION)

TABLE 47 FRANCE: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 48 FRANCE: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS, 2019–2032 (USD MILLION)

TABLE 49 FRANCE: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 50 UK: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019–2032 (USD MILLION)

TABLE 51 UK: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 52 UK: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS, 2019–2032 (USD MILLION)

TABLE 53 UK: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 54 ITALY: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019–2032 (USD MILLION)

TABLE 55 ITALY: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 56 ITALY: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS, 2019–2032 (USD MILLION)

TABLE 57 ITALY: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 58 SPAIN: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019–2032 (USD MILLION)

TABLE 59 SPAIN: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 60 SPAIN: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS, 2019–2032 (USD MILLION)

TABLE 61 SPAIN: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 62 SWITZERLAND: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019–2032 (USD MILLION)

TABLE 63 SWITZERLAND: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 64 SWITZERLAND: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS, 2019–2032 (USD MILLION)

TABLE 65 SWITZERLAND: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 66 NETHERLAND: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019–2032 (USD MILLION)

TABLE 67 NETHERLAND: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 68 NETHERLAND: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS, 2019–2032 (USD MILLION)

TABLE 69 NETHERLAND: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 70 BELGIUM: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019–2032 (USD MILLION)

TABLE 71 BELGIUM: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 72 BELGIUM: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS, 2019–2032 (USD MILLION)

TABLE 73 BELGIUM: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 74 POLAND: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019–2032 (USD MILLION)

TABLE 75 POLAND: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 76 POLAND: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS, 2019–2032 (USD MILLION)

TABLE 77 POLAND: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 78 REST OF EUROPE: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019–2032 (USD MILLION)

TABLE 79 REST OF EUROPE: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 80 REST OF EUROPE: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS, 2019–2032 (USD MILLION)

TABLE 81 REST OF EUROPE: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 82 ASIA-PACIFIC: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY COUNTRY, 2019–2032 (USD MILLION)

TABLE 83 ASIA-PACIFIC: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019–2032 (USD MILLION)

TABLE 84 ASIA-PACIFIC: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 85 ASIA-PACIFIC: PERCUTANEOUS CORONARY INTERVENTION MARKET BY VASCULAR ACCESS, 2019–2032 (USD MILLION)

TABLE 86 ASIA-PACIFIC: PERCUTANEOUS CORONARY INTERVENTION MARKET BY END USER, 2019–2032 (USD MILLION)

TABLE 87 CHINA: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019–2032 (USD MILLION)

TABLE 88 CHINA: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 89 CHINA: PERCUTANEOUS CORONARY INTERVENTION MARKET BY VASCULAR ACCESS, 2019–2032 (USD MILLION)

TABLE 90 CHINA: PERCUTANEOUS CORONARY INTERVENTION MARKET BY END USER, 2019–2032 (USD MILLION)

TABLE 91 JAPAN: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019–2032 (USD MILLION)

TABLE 92 JAPAN: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 93 JAPAN: PERCUTANEOUS CORONARY INTERVENTION MARKET BY VASCULAR ACCESS, 2019–2032 (USD MILLION)

TABLE 94 JAPAN: PERCUTANEOUS CORONARY INTERVENTION MARKET BY END USER, 2019–2032 (USD MILLION)

TABLE 95 INDIA: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019–2032 (USD MILLION)

TABLE 96 INDIA: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 97 INDIA: PERCUTANEOUS CORONARY INTERVENTION MARKET BY VASCULAR ACCESS, 2019–2032 (USD MILLION)

TABLE 98 INDIA: PERCUTANEOUS CORONARY INTERVENTION MARKET BY END USER, 2019–2032 (USD MILLION)

TABLE 99 AUSTRALIA: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019–2032 (USD MILLION)

TABLE 100 AUSTRALIA: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 101 AUSTRALIA: PERCUTANEOUS CORONARY INTERVENTION MARKET BY VASCULAR ACCESS, 2019–2032 (USD MILLION)

TABLE 102 AUSTRALIA: PERCUTANEOUS CORONARY INTERVENTION MARKET BY END USER, 2019–2032 (USD MILLION)

TABLE 103 SOUTH KOREA: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019–2032 (USD MILLION)

TABLE 104 SOUTH KOREA: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 105 SOUTH KOREA: PERCUTANEOUS CORONARY INTERVENTION MARKET BY VASCULAR ACCESS, 2019–2032 (USD MILLION)

TABLE 106 SOUTH KOREA: PERCUTANEOUS CORONARY INTERVENTION MARKET BY END USER, 2019–2032 (USD MILLION)

TABLE 107 SINGAPORE: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019–2032 (USD MILLION)

TABLE 108 SINGAPORE: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 109 SINGAPORE: PERCUTANEOUS CORONARY INTERVENTION MARKET BY VASCULAR ACCESS, 2019–2032 (USD MILLION)

TABLE 110 SINGAPORE: PERCUTANEOUS CORONARY INTERVENTION MARKET BY END USER, 2019–2032 (USD MILLION)

TABLE 111 THAILAND: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019–2032 (USD MILLION)

TABLE 112 THAILAND: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 113 THAILAND: PERCUTANEOUS CORONARY INTERVENTION MARKET BY VASCULAR ACCESS, 2019–2032 (USD MILLION)

TABLE 114 THAILAND: PERCUTANEOUS CORONARY INTERVENTION MARKET BY END USER, 2019–2032 (USD MILLION)

TABLE 115 VIETNAM: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019–2032 (USD MILLION)

TABLE 116 VIETNAM: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 117 VIETNAM: PERCUTANEOUS CORONARY INTERVENTION MARKET BY VASCULAR ACCESS, 2019–2032 (USD MILLION)

TABLE 118 VIETNAM: PERCUTANEOUS CORONARY INTERVENTION MARKET BY END USER, 2019–2032 (USD MILLION)

TABLE 119 REST OF ASIA-PACIFIC: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019–2032 (USD MILLION)

TABLE 120 REST OF ASIA-PACIFIC: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 121 REST OF ASIA-PACIFIC: PERCUTANEOUS CORONARY INTERVENTION MARKET BY VASCULAR ACCESS, 2019–2032 (USD MILLION)

TABLE 122 REST OF ASIA-PACIFIC: PERCUTANEOUS CORONARY INTERVENTION MARKET BY END USER, 2019–2032 (USD MILLION)

TABLE 123 REST OT THE WORLD: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY REGION, 2019–2032 (USD MILLION)

TABLE 124 REST OF WORLD: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019–2032 (USD MILLION)

TABLE 125 REST OF WORLD: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 126 REST OF WORLD: PERCUTANEOUS CORONARY INTERVENTION MARKET BY VASCULAR ACCESS, 2019–2032 (USD MILLION)

TABLE 127 REST OF WORLD: PERCUTANEOUS CORONARY INTERVENTION MARKET BY END USER, 2019–2032 (USD MILLION)

TABLE 128 AFRICA: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019–2032 (USD MILLION)

TABLE 129 AFRICA: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 130 AFRICA: PERCUTANEOUS CORONARY INTERVENTION MARKET BY VASCULAR ACCESS, 2019–2032 (USD MILLION)

TABLE 131 AFRICA: PERCUTANEOUS CORONARY INTERVENTION MARKET BY END USER, 2019–2032 (USD MILLION)

TABLE 132 LATIN AMERICA : PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019–2032 (USD MILLION)

TABLE 133 LATIN AMERICA: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 134 LATIN AMERICA: PERCUTANEOUS CORONARY INTERVENTION MARKET BY VASCULAR ACCESS, 2019–2032 (USD MILLION)

TABLE 135 LATIN AMERICA: PERCUTANEOUS CORONARY INTERVENTION MARKET BY END USER, 2019–2032 (USD MILLION)

TABLE 136 MIDDLE EAST: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019–2032 (USD MILLION)

TABLE 137 MIDDLE EAST: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019–2032 (USD MILLION)

TABLE 138 MIDDLE EAST: PERCUTANEOUS CORONARY INTERVENTION MARKET BY VASCULAR ACCESS, 2019–2032 (USD MILLION)

TABLE 139 MIDDLE EAST: PERCUTANEOUS CORONARY INTERVENTION MARKET BY END USER, 2019–2032 (USD MILLION)

TABLE 140 MAJOR PLAYERS IN THE GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET

TABLE 141 AVERAGE PRICING (USD) AND VOLUME (TOTAL NO OF UNITS), 2022

TABLE 142 AVERAGE PRICING (USD) AND VOLUME (TOTAL NO OF UNITS), 2022

TABLE 143 AVERAGE PRICING (USD) AND VOLUME (TOTAL NO OF UNITS), 2022

TABLE 144 AVERAGE PRICING (USD) AND VOLUME (TOTAL NO OF UNITS), 2022

TABLE 145 AVERAGE PRICING (USD) AND VOLUME (TOTAL NO OF UNITS), 2022

TABLE 146 MOST ACTIVE PLAYER IN THE GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET

TABLE 147 PRODUCT LAUNCH / PRODUCT APPROVAL

TABLE 148 AGREEMENT

TABLE 149 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED

TABLE 150 BOSTON SCIENTIFIC CORPORATION: KEY DEVELOPMENTS

TABLE 151 ABBOTT: PRODUCTS OFFERED

TABLE 152 ABBOTT: KEY DEVELOPMENTS

TABLE 153 MEDTRONIC: PRODUCTS OFFERED

TABLE 154 MEDTRONIC: KEY DEVELOPMENTS

TABLE 155 COOK: PRODUCTS OFFERED

TABLE 156 MERIT MEDICAL SYSTEM: PRODUCTS OFFERED

TABLE 157 TERUMO CORPORATION: PRODUCTS OFFERED

TABLE 158 TERUMO CORPORATION: KEY DEVELOPMENTS

TABLE 159 APT MEDICAL INC: PRODUCTS OFFERED

TABLE 160 BECTON, DICKINSON, AND COMPANY: PRODUCTS OFFERED

TABLE 161 B. BRAUN SE: PRODUCTS OFFERED

TABLE 162 CARDINAL HEALTH: PRODUCTS OFFERED

TABLE 163 MERIL LIFE SCIENCES PVT. LTD: PRODUCTS OFFERED

TABLE 164 PLS MINIMALLY INVASIVE INTERNATIONAL MEDICAL CO LTD: PRODUCTS OFFERED

TABLE 165 MICROPORT SCIENTIFIC CORPORATION: PRODUCTS OFFERED

TABLE 166 MICROPORT SCIENTIFIC CORPORATION: KEY DEVELOPMENTS

TABLE 167 LEPU MEDICAL TECHNOLOGY CO., LTD: PRODUCTS OFFERE